查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886127

全球流感診斷市場

Influenza Diagnostics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球流感診斷市場規模將達49億美元。

全球流感診斷市場規模在2024年估計為36億美元，預計2030年將達到49億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為5.2%。快速診斷測試（RIDT）是本報告分析的細分市場之一，預計複合年成長率將達到6.1%，並在分析期結束時達到20億美元。 RT-PCR細分市場預計在分析期間內複合年成長率為5.1%。

美國市場規模估計為9.476億美元，而中國市場預計將以8.0%的複合年成長率成長。

據估計，2024年美國流感診斷市場規模將達到9.476億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到11億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）將達到8.0%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為2.7%和4.9%。在歐洲，德國預計將以約3.1%的複合年成長率成長。

全球流感診斷市場—主要市場趨勢與促進因素概述

目前流感診斷採用的技術是？

流感診斷對於有效的醫療保健至關重要，尤其是在應對季節性流行和潛在的大流行方面。目前的流感診斷技術包括快速流感診斷測試（RIDT）、逆轉錄-聚合酵素鏈鎖反應（RT-PCR）和病毒培養。 RIDT 的優點在於快速出結果，可在 30 分鐘內提供結果，有助於快速做出臨床決策。然而，由於 RT-PCR 具有高靈敏度和特異性，能夠區分不同的流感病毒株，因此被認為是流感診斷的黃金標準。病毒培養雖然由於週轉時間較長而應用較少，但仍是流行病學研究和疫苗研發的重要工具。近年來，多重檢測技術的出現取得了進展，該技術可以同時檢測流感病毒和其他呼吸道病原體，從而提高了檢測的效率和整體性。

患者需求如何改變流感診斷？

隨著醫療保健消費者（患者）的認知水平不斷提高，對快速、準確、便捷的診斷方法的需求日益成長。這種轉變推動了照護現場（POC​​）技術的發展，這些檢測可以在傳統檢查室以外的多種場所（例如藥房和家中）進行。這些檢測旨在方便使用者操作，只需極少的專業技能即可快速獲得結果，從而縮短等待時間，加快啟動適當的治療。這種以患者為中心的方法不僅改善了個人健康狀況，還有助於限制病毒在社區的傳播，凸顯了流感診斷的可及性和速度的重要性。

科技如何影響流感診斷的發展？

技術創新是流感診斷技術發展的主要驅動力。包括遠端醫療和行動醫療應用在內的數位健康技術的興起，在流感防治中發揮關鍵作用。這些技術能夠實現遠距離診斷和監測，這在流感高峰期和疫情大流行期間尤其重要，因為此時醫療機構往往不堪重負。此外，基因定序和生物資訊學的進步提高了病毒株鑑定的準確性和速度，這對於有效的治療和疫苗策略至關重要。能夠檢測早期流感症狀的生物感測器和穿戴式裝置的開發，也是實現早期檢測和介入的一個極具前景的研究方向。

流感診斷市場的成長受以下幾個因素驅動：

流感診斷市場的成長受多種因素驅動，包括全球季節性流感發病率的上升以及人們對流感大流行威脅的日益關注。快速的都市化和國際旅行加速了病毒的傳播，從而催生了對可靠診斷解決方案的全球性需求。診斷技術的進步，特別是快速檢測和基因分析技術的進步，顯著提高了流感診斷的反應速度和準確性。政府在感染疾病防治方面的措施和資金投入也進一步推動了診斷市場的擴張。此外，人工智慧（AI）和機器學習在診斷流程中的應用增強了數據分析和解讀能力，從而實現了更精準、更具預測性的診斷。隨著全球醫療衛生系統將預防性護理和早期療育置於優先地位，對先進、快速的流感診斷解決方案的需求持續成長，確保了該領域的持續發展。

部分：

檢測類型（快速診斷檢測、RT-PCR、細胞培養、其他檢測類型）、最終用途（醫院、即時檢測、檢查室）

受訪公司範例

  • Alere, Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片文字稿、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭格局的變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降和供應鏈重組，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12713

Global Influenza Diagnostics Market to Reach US$4.9 Billion by 2030

The global market for Influenza Diagnostics estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. RIDT, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the RT-PCR segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$947.6 Million While China is Forecast to Grow at 8.0% CAGR

The Influenza Diagnostics market in the U.S. is estimated at US$947.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Influenza Diagnostics Market - Key Trends & Drivers Summarized

What Are the Current Technologies in Influenza Diagnostics?

Influenza diagnostics have become critical for effective healthcare delivery, especially in managing seasonal outbreaks and potential pandemics. Current technologies in influenza diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR), and viral cultures. RIDTs offer the advantage of speed, providing results in less than 30 minutes, which facilitates swift clinical decisions. However, RT-PCR is the gold standard for influenza diagnostics due to its high sensitivity and specificity, capable of distinguishing between different influenza strains. Viral culture, while less common due to its longer turnaround time, remains an important tool for epidemiological studies and vaccine development. Recent advancements also include the integration of multiplex assays that can detect influenza alongside other respiratory pathogens, enhancing the efficiency and comprehensiveness of testing.

How Are Patient Demands Transforming Influenza Diagnostics?

As healthcare consumers become more informed, there is a growing demand for quicker, more accurate diagnostic methods that can be accessed conveniently. This shift is driving the development of point-of-care (POC) tests that can be administered in various settings outside the traditional laboratory environment, such as pharmacies or at home. These tests are designed to be user-friendly, requiring minimal technical skills and providing rapid results to reduce the waiting period and accelerate the initiation of appropriate treatments. This patient-centric approach not only improves individual health outcomes but also aids in controlling the spread of the virus in community settings, highlighting the importance of accessibility and speed in influenza diagnostics.

What Impact Does Technology Have on the Evolution of Influenza Diagnostics?

Technological innovation is a key driver in the evolution of influenza diagnostics. The emergence of digital health technologies, including telehealth and mobile health apps, is playing a crucial role in the management of influenza. These technologies allow for remote diagnosis and monitoring, which is particularly beneficial during peak flu seasons or pandemics when healthcare facilities are overwhelmed. Additionally, advancements in genetic sequencing and bioinformatics have improved the accuracy and speed of strain identification, which is vital for effective treatment and vaccination strategies. The ongoing development of biosensors and wearable devices that can detect early symptoms of influenza represents another promising frontier, potentially enabling even earlier detection and intervention.

Growth in the Influenza Diagnostics Market Is Driven by Several Factors…

The growth in the influenza diagnostics market is driven by several factors, including the increased global incidence of seasonal influenza and heightened awareness of pandemic threats. Rapid urbanization and international travel contribute to the faster spread of the virus, necessitating robust diagnostic solutions globally. Advances in diagnostic technologies, particularly in rapid testing and genetic analysis, have significantly improved the response time and accuracy of influenza diagnostics. Government initiatives and funding for infectious disease control further support the expansion of the diagnostics market. Additionally, the integration of artificial intelligence and machine learning in diagnostic processes enhances data analysis and interpretation, leading to more precise and predictive diagnostics. As healthcare systems worldwide prioritize preventive care and early intervention, the demand for advanced, rapid influenza diagnostic solutions continues to rise, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Influenza Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (RIDT, RT-PCR, Cell Culture, Other Test Types); End-Use (Hospitals, POCT, Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 38 Featured) -

  • Alere, Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Influenza Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Seasonal and Pandemic Influenza Spurs Demand for Rapid Diagnostic Solutions
    • Advancements in Molecular Diagnostic Technologies Propel Growth in Influenza Testing
    • Increasing Focus on Early Detection and Prevention Expands Addressable Market for Influenza Diagnostics
    • Growing Adoption of Point-of-Care Testing Drives Demand for Rapid Influenza Diagnostic Kits
    • Stringent Regulatory Approvals and Guidelines Strengthen Business Case for High-Accuracy Diagnostic Solutions
    • Rising Awareness of Flu Vaccination Correlates with Increased Demand for Diagnostic Testing
    • Innovation in Multiplex Assays Generates Opportunities for Comprehensive Respiratory Disease Screening
    • AI and Machine Learning Enhance Diagnostic Accuracy and Predictive Analytics in Influenza Testing
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Demand for At-Home Influenza Testing Kits
    • Increasing Healthcare Investments in Emerging Markets Propel Growth in Influenza Diagnostics
    • Rising Demand for Digital Health Platforms Drives Adoption of Connected Diagnostic Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RIDT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RIDT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for RIDT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for POCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for POCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for POCT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Influenza Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Influenza Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Influenza Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Influenza Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Influenza Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Influenza Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION